Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

Atopic Dermatitis

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

JAMA Dermatol.

Thorsteinsdottir S, Stokholm J, Thyssen JP, Nørgaard S, Thorsen J, Chawes BL, Bønnelykke K, Waage J, Bisgaard H

doi: 10.1001/jamadermatol.

COMMENTED

Atopic Dermatitis

Association between parental autoimmune disease and atopic dermatitis in their offspring: a matched case-control study

doi: 10.1111/jdv.15413.

Atopic Dermatitis

Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial

Br J Dermatol.

Tsianakas A, Luger TA, Radin A

doi: 10.1111/bjd.15905.

Osteoarthritis

Patients' Pre-Operative Expectations of Total Knee Arthroplasty and Satisfaction with Outcomes at One Year: A Prospective Cohort Study

Arthritis Rheumatol.

Hawker GA, Conner-Spady BL, Bohm E, Dunbar MJ, Jones CA, Ravi B, Noseworthy T, Dick D, Powell J, Paul P, Marshall DA, BEST-Knee Study Team.

doi: 10.1002/art.41510.

Atopic Dermatitis

Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study

J Am Acad Dermatol.

Fishbein AB, Mueller K, Kruse L, Boor P, Sheldon S, Zee P, Paller AS

doi: 10.1016/j.jaad.2017.08.043.

Atopic Dermatitis

Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled, severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study

Br J Dermatol

Cork MJ, Thaçi D, Eichenfield LF, Arkwright PD, Sun X, Chen Z, Akinlade B, Boklage S, Guillemin I, Kosloski MP, Kamal MA, O'Malley JT, Patel N, Graham NMH, Bansal A

doi: 10.1111/bjd.19460

Atopic Dermatitis

Is atopic dermatitis associated with obesity? A systematic review of observational studies

J Eur Acad Dermatol Venereol.

Ali Z, Suppli Ulrik C, Agner T, Thomsen SF

doi: 10.1111/jdv.14879.

Psoriasis

Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients

JAMA Dermatol.

Bruins FM, Bronckers IMGJ, Groenewoud HMM, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB

doi: 10.1001/jamadermatol.2019.3717.

Atopic Dermatitis

Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials

Dermatol Ther (Heidelb).

Simpson EL

doi: 10.1007/s13555-017-0181-6.

Related content

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

Association between parental autoimmune disease and atopic dermatitis in their offspring: a matched case-control study

Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial

Patients' Pre-Operative Expectations of Total Knee Arthroplasty and Satisfaction with Outcomes at One Year: A Prospective Cohort Study

Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study

Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled, severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study

Is atopic dermatitis associated with obesity? A systematic review of observational studies

Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients

Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials